Tagintegrase inhibitors

FDA Approves Cabenuva, the First Complete Long-Acting Injectable HIV Treatment

1 Min Read

Poz.com, January 21, 2021 On January 21, the Food and Drug Administration (FDA) in the USA approved the first complete injectable HIV treatment regimen that does not require daily pills. Cabenuva, from ViiV Healthcare, is administered only once a month. It is approved for people with an undetectable viral load on their current therapy who wish to switch to a long-acting regimen. Cabenuva consists...

Read on Read later

New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir

By J Pope

In Contraception, HIV, Pregnancy choices, Reproductive health

1 Min Read

European Medicines Agency, 18/05/2018 The European Medicines Agency (EMA) is evaluating preliminary results from a study which found 4 cases of birth defects such as spina bifida (malformed spinal cord) in babies born to mothers who became pregnant while taking dolutegravir. While EMA is assessing the new evidence it has issued the following precautionary advice: Dolutegravir HIV medicines should...

Read on Read later